SoftBank is transitioning from a traditional telecommunications carrier into an AI infrastructure provider, orchestrating intelligence across distributed edge and cloud environments to enable devices, robots,…
Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with…
BARCELONA, Spain, March 5, 2026 /PRNewswire/ -- At the Huawei Product & Solution Launch during MWC Barcelona 2026, Yuan Yuan,…
BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- At the Huawei AI DC Innovation Forum at MWC Barcelona 2026, Huawei unveiled…
BENGALURU, India and BARCELONA, Spain, March 4, 2026 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced the launch of…
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and…
March 01, 2026 09:45 ET | Source: Celldex Therapeutics, Inc. - Late breaking Poster Presentation at AAAAI -- Ability to…
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026…
February 28, 2026 09:45 ET | Source: Cogent Biosciences, Inc. Bezuclastinib mean TSS reduction deepens to –32.0 points at 48…
Largest integrated portal enabling sharper, faster decisions via seamless macro-to-micro coverageMUMBAI, India, Feb. 27, 2026 /PRNewswire/ -- Crisil today rolled…